#MedicalCannabis
#MedicalCannabis · page 4
- Pharmaceutical
Leading German Pharma Company Launches Medical Cannabis Range Into Fast-Growing Domestic Market
ONE of Germany’s largest pharmaceutical firms has entered the medical cannabis space with the launch of a two flower products – and six more products to follow.
- Pharmaceutical
Work On £12m Medicinal Cannabis Cultivation Facility Held-Up By Covid-19 UK Travel Ban
ANANDA Developments has secured £300,000 to build out the first phase of its medicinal cannabis growing research facility in Lincolnshire.
- Companies
Kanabo Group Joins LSE With ’50 More Cannabis Companies’ Set To Follow
MEDICAL cannabis device maker Kanabo Group will today become the second cannabis company to list on the London Stock Exchange.
- Pharmaceutical
World’s Largest Cannabis Deal Sees UK Firm GW Pharma Bought For $7.2bn
IRISH firm Jazz Pharmaceuticals has agreed to purchase UK medical cannabis trailblazer GW Pharmaceuticals for $7.2bn.
- Companies
Six Companies Chosen to Supply Products – Free Of Charge – To France’s First Medical Cannabis Trial
SIX companies have seen their products selected for use in the French medical cannabis trial for 3,000 patients which is set to begin with weeks The French Government first announced it was launching a pilot medical cannabis programme back in October 2019, but Covid-19 delayed its launch.
- Medical
Children’s Dutch Epilepsy Cannabis Medicines Will Be Made In The UK To Overcome Import Impasse
A PERMANENT solution to the import impasse on children’s epilepsy cannabis medication has emerged with the Dutch manufacturer set to see the medicines made in the UK.
- Medical
The UK Medical Cannabis Industry Can – And Does – Provide Epilepsy Medicines For Children In Post-Brexit Britain
Pierre Van Weperen of Grow Pharma on the post-Brexit issue surrounding the import of epilepsy cannabis medicines into the UK.
- Cultivation
Work Gets Underway On Scotland’s First Medical Cannabis Cultivation and Production Facility
SCOTLAND’S first home-grown cannabis medicines could be in UK patients’ hands in early 2022 after work started on a new £15m cultivation and production facility in the Borders.
- Opinion
‘The Dutch Bedrocan Medicine Is The Only Viable Option For Treating Many Children’s Epilepsy’
Prof Mike Barnes, one of the UK’s leading cannabis clinicians responds to suggestions that the medicines for UK children with epilepsy can be sourced domestically.
- Medical
‘Repeat & Scale’: Grow Group Set For Expansion Into Germany, Europe And Beyond
UK innovator Grow Group is raising £6m to fund its expansion into Europe – with aims to be the global powerhouse of cannabis medicines by 2025.
- Pharmaceutical
New Patient Data App Can Help Clear The Hurdles To Medical Cannabis Scripts
SECURING patient-generated data and enabling them to speak the language of the health-care system is at the heart of a ground-breaking development by UK cannabis firm Alta Flora.
- Opinion
Cannabis Medicine Transforms Student’s Life Leaving Her With A ‘CAN DO’ Attitude
Forzana Nasir – one of the UK’s first medical cannabis patients – tells Sue Kirby how it has changed her life as she prepares to launch a new patient advocacy service: Can Do.
